vTv Therapeutics Inc

(NASDAQ:VTVT)

Latest On vTv Therapeutics Inc (VTVT):

Date/Time Type Description Signal Details
2023-05-24 23:27 ESTNewsvTv gains 13% on patent win for potential brain tumor pillN/A
2023-05-12 02:13 ESTNewsvTv Therapeutics GAAP EPS of -$0.06 beats by $0.05N/A
2022-12-13 14:03 ESTNewsvTv Therapeutics names Steven Tuch as CFON/A
2022-11-11 01:03 ESTNewsvTv Therapeutics GAAP EPS of -$0.05N/A
2022-08-16 16:02 ESTNewsvTv Therapeutics GAAP EPS of -$0.04N/A
2022-07-27 11:17 ESTNewsPaul Sekhri to join vTv Therapeutics as CEON/A
2022-07-25 19:58 ESTNewsvTv stock soars 18% on $10M equity investment by CinRx PharmaN/A
2022-06-01 22:41 ESTNewsvTv Therapeutics surges on licensing deal for diabetes candidateN/A
2022-05-13 02:33 ESTNewsvTv Therapeutics GAAP EPS of -$0.10, revenue of $2MN/A
2022-03-30 09:07 ESTNewsvTv Therapeutics GAAP EPS of -$0.11N/A
2021-12-07 00:30 ESTNewsvTv Therapeutics rises after hours following restructuring plan; 65% workforce reductionN/A
2021-11-09 19:30 ESTNewsvTv Therapeutics EPS beats by $0.05, beats on revenueN/A
2021-10-20 17:49 ESTNewsvTv Therapeutics appoints new CEON/A
2021-10-12 15:02 ESTNewsvTv Therapeutics says primary endpoint achieved for TTP399 in type 1 diabetes studyN/A
2021-09-24 15:59 ESTNewsvTv rises 26% after-hours on ascending dose study data, plans for phase 2 trialN/A
2021-08-04 17:43 ESTNewsvTv Therapeutics reports Q2 resultsN/A
2021-07-22 08:15 ESTNewsvTv Therapeutics and Cantex ink licensing agreement for azeliragon developmentN/A
2021-05-06 01:30 ESTNewsvTv Therapeutics EPS misses by $0.03, beats on revenueN/A
2021-04-13 22:04 ESTNewsvTv Therapeutics shares surge as TTP399 wins FDA 'Breakthrough Therapy' statusN/A
2021-04-13 22:04 ESTNewsMRNA, NVAX, RIOT and MARA among premarket gainersN/A
2021-03-19 04:43 ESTNewsvTv Therapeutics starts TTP399 diabetes studyN/A
2021-02-26 04:54 ESTEarnings EstimateAn EPS average of -$0.04 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-26 04:54 ESTEarnings EstimateAn EPS average of -$0.03 is estimated for the quarter ending on March 31, 2021.Sell
2021-02-26 04:54 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 12:29 ESTNewsvTv Therapeutics EPS beats by $0.08, beats on revenueN/A
2021-02-23 22:59 ESTNewsvTv Therapeutics posts data from mid-stage TTP399 diabetes studyN/A
2021-02-18 05:19 ESTNewsvTv Therapeutics starts multiple ascending dose study of HPP737 as psoriasis treatmentN/A
2021-01-22 21:46 ESTNewsvTv Therapeutics amends licensing deal with Huadong PharmaceuticalN/A
2021-01-15 17:20 ESTNewsvTv Therapeutics files to increase ATM offeringN/A
2020-12-17 13:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $7 to $6.75.Neutral
2020-12-16 13:56 ESTNewsvTv Therapeutics azeliragon flunks in mid-stage alzheimer’s and diabetes studyN/A
2020-12-15 20:28 ESTNewsvTv Therapeutics inks licensing deal for HPP971, shares up 11%N/A
2020-12-11 13:45 ESTNewsMacAndrews & Forbes buys 625K shares of vTv TherapeuticsN/A
2020-11-26 21:59 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 09:09 ESTNewsvTv Therapeutics raises $47M via stock purchase agreementN/A
2020-11-09 05:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 01:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 18:41 ESTNewsvTv Therapeutics reports Q3 resultsN/A
2020-11-04 14:39 ESTNewsVTv Therapeutics' Elevage study suggests comparability to diabetes subgroup of Phase 3 STEADFAST studyN/A
2020-09-26 14:32 ESTFinancialsCompany financials have been released.Neutral
2020-09-23 20:43 ESTNewsVTv Therapeutics +14% on positive TTP399 data in type 1 diabetesN/A
2020-09-17 09:28 ESTNewsAn In-Depth Look At vTv TherapeuticsN/A
2020-09-17 06:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 10:32 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 01:58 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:53 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 09:59 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on September 30, 2020.Sell
2020-08-04 00:19 ESTNewsvTv Therapeutics EPS beats by $0.03N/A
2020-07-30 18:17 ESTFinancialsCompany financials have been released.Neutral

About vTv Therapeutics Inc (VTVT):

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant PDE4 inhibitor that addresses inflammatory diseases. It is also involved in the clinical development of other programs, including a small molecule GLP-1r agonist; the PDE4 inhibitor; HPP737, a PPAR-delta agonist; and an Nrf2 activator through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; Novo Nordisk A/S; and Columbia University. The company was founded in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.

VTVT Quotes by TradingView

See Advanced Chart

General

  • Name vTv Therapeutics Inc
  • Symbol VTVT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 25
  • Fiscal Year EndDecember
  • IPO Date2015-07-30
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.vtvtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 19.84
  • Enterprise Value Revenue 33.19
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.49
  • Profit Margin -133%
  • Operating Margin -185%
  • Return on Assets -62%
  • Revenue 6.41 million
  • Earnings Per Share -$0.56
  • Revenue Per Share $0.14
  • Gross Profit -4601000
  • Quarterly Earnings Growth 91314.3%
View More

Highlights

  • Market Capitalization 245.16 million
  • EBITDA -10758000
  • Analyst Target Price $6.75
  • Book Value Per Share -$1.67
View More

Share Statistics

  • Shares Outstanding 54.55 million
  • Shares Float 20.73 million
  • % Held by Insiders 7238%
  • % Held by Institutions 8.01%
  • Shares Short 2.52 million
  • Shares Short Prior Month 3.06 million
  • Short Ratio 0.37
  • Short % of Float 11%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta -1.85
  • 52 Week High $3.59
  • 52 Week Low $1.5
  • 50 Day Moving Average 2.54
  • 200 Day Moving Average 2.09
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

vTv Therapeutics Inc (VTVT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

vTv Therapeutics Inc (VTVT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.03-$0.06154.55%
2020-09-302020-11-05$N/A-$0.03-$0.1171.43%
2020-06-302020-08-03$N/A-$0.07-$0.1026.32%
2020-03-312020-05-07$8000-$0.11-$0.10-10%
2019-12-312020-02-21$7000-$0.13-$0.05-160%
2019-09-302019-10-30$8000-$0.13-$0.06-116.67%
2019-06-302019-07-31$1.83 million-$0.10-$0.05-100%
2019-03-312019-05-01$921000-$0.26
2018-12-312019-02-26$4.52 million-$0.05-$0.1154.55%
2018-09-302018-11-08$3.38 million-$0.06-$0.1250%
2018-06-302018-08-03$2.47 million-$0.31-$0.25-24%
2018-03-312018-05-15$2.06 million-$0.30-$0.3513.47%
2017-12-312018-02-27$233000-$0.44-$0.42-6.02%
2017-09-302017-11-01$15000-$0.38-$0.416.17%
2017-06-302017-08-02$13000-$0.41-$0.434.65%
2017-03-312017-05-03$30000-$0.44-$0.440.74%
2016-12-312017-02-24$38000-$0.42-$0.5015.44%
2016-09-302016-11-02$38000-$0.41-$0.4610.48%
2016-06-302016-08-02$182000-$0.47-$0.8544.87%
2016-03-312016-05-12$376000-$0.42-$0.5522.94%
2015-12-312016-03-01$226000-$0.35-$0.6546.15%
2015-09-302015-11-12$133000-$0.49-$1.1758.12%
2015-06-302015-07-30$110000-$1.12-$1.03-8.74%

vTv Therapeutics Inc (VTVT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A 2.51 million 4.2 million 4.41 million
Income Before Tax N/A N/A -4.99 million -7.17 million -6.88 million
Selling General Administrative N/A N/A 1.7 million 2.45 million 1.99 million
Gross Profit N/A N/A N/A N/A 7000
Ebit N/A N/A -4.75 million -6.97 million -6.39 million
Operating Income N/A N/A -4.2 million -6.65 million -6.39 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A 8000 7000
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A -565000 -363000 -494000
Net Income From Continuing Operations N/A N/A -4.99 million -7.17 million -6.88 million
Net Income Applicable to Common Shares 1.13 million -1.53 million -3.37 million -4.72 million -4.4 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities -976000 -715000 323000 N/A -1.43 million
Total Cash Flow from Investing Activities N/A N/A N/A N/A 310000
Net Borrowings -1.58 million N/A -1.81 million N/A -2.14 million
Total Cash Flow from Financial Activities N/A 8.28 million N/A N/A 6.86 million
Change to Operating Activities -1.73 million -1000 465000 N/A -988000
Change in Cash N/A 3.49 million N/A N/A 974000
Total Cash from Operating Activities -5.43 million -4.79 million -5.56 million N/A -6.2 million
Depreciation N/A 22000 N/A N/A 8000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A 1.81 million
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income -1.36 million -872000 -1.7 million N/A -2.11 million
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A 80.16 million 69.21 million 18.11 million
Total Stockholder Equity N/A N/A -69.53 million -61.82 million -49.02 million
Other Current Liabilities 31000 31000 N/A N/A 31000
Total Assets N/A N/A 10.63 million 7.39 million 9.27 million
Common Stock 773000 724000 711000 679000 641000
Other Current Assets N/A N/A N/A 2.5 million N/A
Retained Earnings -290.04 million -253.34 million -268.87 million -252.7 million -233.52 million
Other Liabilities 3.93 million 3.81 million 4.61 million 4.25 million 3.89 million
Other Assets N/A N/A 444000 444000 2.94 million
Cash N/A N/A 6.39 million 406000 1.78 million
Total Current Liabilities 6.39 million 8.3 million 11.41 million 11.97 million 13.38 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 849000 888000 926000 963000 1 million
Total Current Assets 7.22 million 3.68 million 6.78 million 3.5 million 2.84 million
Long Term Investments N/A N/A 2.48 million 2.48 million 2.48 million
Net Tangible Assets -80.1 million -51.37 million -69.53 million -61.82 million -49.02 million
Short Term Investments N/A N/A N/A N/A 250000
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 6.12 million 5.75 million N/A N/A 7.07 million

vTv Therapeutics Inc (VTVT) Chart:

vTv Therapeutics Inc (VTVT) News:

Below you will find a list of latest news for vTv Therapeutics Inc (VTVT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

vTv Therapeutics Inc (VTVT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest VTVT Trades:

Date Shares Price
Jun 13, 2022 7:53 PM EST100$0.7255
Jun 13, 2022 7:53 PM EST100$0.7255
Jun 13, 2022 7:54 PM EST100$0.7255
Jun 13, 2022 7:54 PM EST100$0.7255
Jun 13, 2022 7:55 PM EST100$0.726

vTv Therapeutics Inc (VTVT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020030673/0001564590-20-030673-index.htm
2019-07-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1641489/000000000019011036/0000000000-19-011036-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1641489/000003877719000071/0000038777-19-000071-index.htm
2019-02-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000089882219000017/0000898822-19-000017-index.htm
2019-01-04DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000095014219000022/0000950142-19-000022-index.htm
2019-07-09DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000095014219001539/0000950142-19-001539-index.htm
2019-07-11CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1641489/000095014219001547/0000950142-19-001547-index.htm
2018-12-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036118045003/0001140361-18-045003-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036118045004/0001140361-18-045004-index.htm
2018-12-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036118045974/0001140361-18-045974-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036118045975/0001140361-18-045975-index.htm
2019-01-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119001285/0001140361-19-001285-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119001287/0001140361-19-001287-index.htm
2019-01-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119001938/0001140361-19-001938-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119001940/0001140361-19-001940-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119003319/0001140361-19-003319-index.htm
2019-02-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119003321/0001140361-19-003321-index.htm
2019-03-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119005227/0001140361-19-005227-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119005231/0001140361-19-005231-index.htm
2019-05-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119009236/0001140361-19-009236-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119009238/0001140361-19-009238-index.htm
2019-06-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119011601/0001140361-19-011601-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119011603/0001140361-19-011603-index.htm
2019-07-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119012651/0001140361-19-012651-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119012655/0001140361-19-012655-index.htm
2019-08-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119014344/0001140361-19-014344-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119014349/0001140361-19-014349-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119015323/0001140361-19-015323-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119015481/0001140361-19-015481-index.htm
2019-09-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016098/0001140361-19-016098-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016100/0001140361-19-016100-index.htm
2019-09-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016522/0001140361-19-016522-index.htm
2019-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016526/0001140361-19-016526-index.htm
2019-09-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016917/0001140361-19-016917-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119016918/0001140361-19-016918-index.htm
2019-09-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119017443/0001140361-19-017443-index.htm
2019-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119017447/0001140361-19-017447-index.htm
2019-10-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119019004/0001140361-19-019004-index.htm
2019-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119019008/0001140361-19-019008-index.htm
2019-11-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119020345/0001140361-19-020345-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119020346/0001140361-19-020346-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119021508/0001140361-19-021508-index.htm
2019-11-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119021509/0001140361-19-021509-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119022838/0001140361-19-022838-index.htm
2019-12-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119022840/0001140361-19-022840-index.htm
2019-12-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036119023100/0001140361-19-023100-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036119023102/0001140361-19-023102-index.htm
2020-01-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036120000400/0001140361-20-000400-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036120000401/0001140361-20-000401-index.htm
2020-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036120001598/0001140361-20-001598-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036120001599/0001140361-20-001599-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036120004007/0001140361-20-004007-index.htm
2020-02-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036120004008/0001140361-20-004008-index.htm
2020-05-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1641489/000114036120011440/0001140361-20-011440-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000114036120011442/0001140361-20-011442-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000120919119014460/0001209191-19-014460-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019001842/0001562180-19-001842-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019001843/0001562180-19-001843-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019001844/0001562180-19-001844-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019002469/0001562180-19-002469-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019002470/0001562180-19-002470-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019002471/0001562180-19-002471-index.htm
2019-09-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019004846/0001562180-19-004846-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019004847/0001562180-19-004847-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218019005800/0001562180-19-005800-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020002397/0001562180-20-002397-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020003677/0001562180-20-003677-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020004480/0001562180-20-004480-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020004481/0001562180-20-004481-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020004482/0001562180-20-004482-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020004483/0001562180-20-004483-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020004484/0001562180-20-004484-index.htm
2020-09-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156218020005837/0001562180-20-005837-index.htm
2018-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459018030816/0001564590-18-030816-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459018031470/0001564590-18-031470-index.htm
2019-01-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019000791/0001564590-19-000791-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019001404/0001564590-19-001404-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019003013/0001564590-19-003013-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019003201/0001564590-19-003201-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1641489/000156459019004516/0001564590-19-004516-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019004697/0001564590-19-004697-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019005492/0001564590-19-005492-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019007192/0001564590-19-007192-index.htm
2019-03-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1641489/000156459019007932/0001564590-19-007932-index.htm
2019-03-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1641489/000156459019007933/0001564590-19-007933-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019008524/0001564590-19-008524-index.htm
2019-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641489/000156459019008563/0001564590-19-008563-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459019014845/0001564590-19-014845-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019014851/0001564590-19-014851-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019019524/0001564590-19-019524-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019023605/0001564590-19-023605-index.htm
2019-07-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1641489/000156459019024605/0001564590-19-024605-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019024689/0001564590-19-024689-index.htm
2019-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459019027516/0001564590-19-027516-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019027519/0001564590-19-027519-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019029397/0001564590-19-029397-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019034085/0001564590-19-034085-index.htm
2019-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019034516/0001564590-19-034516-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019034826/0001564590-19-034826-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019034971/0001564590-19-034971-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019035920/0001564590-19-035920-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019037756/0001564590-19-037756-index.htm
2019-10-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459019038844/0001564590-19-038844-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019038845/0001564590-19-038845-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019042965/0001564590-19-042965-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019044554/0001564590-19-044554-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019044950/0001564590-19-044950-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019046321/0001564590-19-046321-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459019046717/0001564590-19-046717-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020000393/0001564590-20-000393-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020002288/0001564590-20-002288-index.htm
2020-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1641489/000156459020005627/0001564590-20-005627-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020005628/0001564590-20-005628-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020006410/0001564590-20-006410-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020015745/0001564590-20-015745-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020018558/0001564590-20-018558-index.htm
2020-04-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1641489/000156459020018575/0001564590-20-018575-index.htm
2020-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1641489/000156459020019961/0001564590-20-019961-index.htm
2020-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1641489/000156459020019964/0001564590-20-019964-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459020022936/0001564590-20-022936-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020022944/0001564590-20-022944-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020024688/0001564590-20-024688-index.htm
2020-05-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1641489/000156459020026761/0001564590-20-026761-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020029371/0001564590-20-029371-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020030673/0001564590-20-030673-index.htm
2020-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459020035526/0001564590-20-035526-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020035549/0001564590-20-035549-index.htm
2020-08-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1641489/000156459020035552/0001564590-20-035552-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020042075/0001564590-20-042075-index.htm
2020-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020045756/0001564590-20-045756-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020047500/0001564590-20-047500-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1641489/000156459020051377/0001564590-20-051377-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1641489/000156459020051429/0001564590-20-051429-index.htm
2019-10-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156761919019527/0001567619-19-019527-index.htm
2020-01-17DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1641489/000156761920001243/0001567619-20-001243-index.htm
2019-07-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1641489/999999999519001607/9999999995-19-001607-index.htm

vTv Therapeutics Inc (VTVT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of vTv Therapeutics Inc (VTVT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 7238%
Institutional Ownership: 801%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-27RONALD O PERELMAN10% Share HolderBuy815,217.001.841,499,999.2813,232,785.00https://www.sec.gov/Archives/edgar/data/1641489/000114036118045975/0001140361-18-045975-index.htm
2019-01-16RONALD O PERELMAN10% Share HolderBuy815,217.001.841,499,999.2814,048,002.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119001287/0001140361-19-001287-index.htm
2019-01-29RONALD O PERELMAN10% Share HolderBuy815,217.001.841,499,999.2814,863,219.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119001940/0001140361-19-001940-index.htm
2020-05-15HERSH KOZLOVDirectorBuy10,000.003.0030,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1641489/000156218020003677/0001562180-20-003677-index.htm
2019-02-14RONALD O PERELMAN10% Share HolderBuy815,217.001.841,499,999.2815,678,436.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119003319/0001140361-19-003319-index.htm
2019-02-28RONALD O PERELMAN10% Share HolderBuy815,217.001.841,499,999.2816,493,653.00https://www.sec.gov/Archives/edgar/data/1641489/000120919119014460/0001209191-19-014460-index.htm
2019-05-15RONALD O PERELMAN10% Share HolderBuy1,358,698.001.842,500,004.3217,852,351.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119009238/0001140361-19-009238-index.htm
2019-06-25RONALD O PERELMAN10% Share HolderBuy1,212,121.001.651,999,999.6519,064,472.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119011603/0001140361-19-011603-index.htm
2019-07-09RONALD O PERELMAN10% Share HolderBuy1,212,121.001.651,999,999.6520,276,593.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119012655/0001140361-19-012655-index.htm
2019-08-06RONALD O PERELMAN10% Share HolderBuy1,212,121.001.651,999,999.6521,488,714.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119014349/0001140361-19-014349-index.htm
2019-08-19RONALD O PERELMAN10% Share HolderBuy150,000.001.31195,900.0021,638,714.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119015323/0001140361-19-015323-index.htm
2019-08-22RONALD O PERELMAN10% Share HolderBuy50,000.001.3869,000.0021,688,714.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119015481/0001140361-19-015481-index.htm
2019-09-04RONALD O PERELMAN10% Share HolderBuy606,061.001.651,000,000.6522,294,775.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119016100/0001140361-19-016100-index.htm
2019-09-11RONALD O PERELMAN10% Share HolderBuy606,061.001.651,000,000.6522,900,836.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119016526/0001140361-19-016526-index.htm
2019-03-10JEFFREY B KINDLERExecutive ChairmanBuy11,666.0023,333.00https://www.sec.gov/Archives/edgar/data/1641489/000156218019001844/0001562180-19-001844-index.htm
2019-09-18RONALD O PERELMAN10% Share HolderBuy606,061.001.651,000,000.6523,506,897.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119016918/0001140361-19-016918-index.htm
2019-09-27RONALD O PERELMAN10% Share HolderBuy1,369,863.001.461,999,999.9824,876,760.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119017447/0001140361-19-017447-index.htm
2019-10-24RONALD O PERELMAN10% Share HolderBuy1,369,863.001.461,999,999.9826,246,623.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119019008/0001140361-19-019008-index.htm
2019-11-12RONALD O PERELMAN10% Share HolderBuy1,369,863.001.461,999,999.9827,616,486.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119020346/0001140361-19-020346-index.htm
2019-11-26RONALD O PERELMAN10% Share HolderBuy1,369,863.001.461,999,999.9828,986,349.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119021508/0001140361-19-021508-index.htm
2019-12-18RONALD O PERELMAN10% Share HolderBuy1,369,863.001.461,999,999.9830,356,212.00https://www.sec.gov/Archives/edgar/data/1641489/000114036119022838/0001140361-19-022838-index.htm
2020-01-07RONALD O PERELMAN10% Share HolderBuy1,250,000.001.602,000,000.0031,606,212.00https://www.sec.gov/Archives/edgar/data/1641489/000114036120000401/0001140361-20-000401-index.htm
2020-01-28RONALD O PERELMAN10% Share HolderBuy1,250,000.001.602,000,000.0032,856,212.00https://www.sec.gov/Archives/edgar/data/1641489/000114036120001599/0001140361-20-001599-index.htm
2020-02-25RONALD O PERELMAN10% Share HolderBuy1,250,000.001.602,000,000.0034,106,212.00https://www.sec.gov/Archives/edgar/data/1641489/000114036120004007/0001140361-20-004007-index.htm
2020-05-12RONALD O PERELMAN10% Share HolderBuy625,000.001.601,000,000.0034,731,212.00https://www.sec.gov/Archives/edgar/data/1641489/000114036120011442/0001140361-20-011442-index.htm
2020-03-10JEFFREY B KINDLERDirectorBuy11,667.0035,000.00https://www.sec.gov/Archives/edgar/data/1641489/000156218020002397/0001562180-20-002397-index.htm
2019-09-13HERSH KOZLOVDirectorBuy5,000.001.658,250.005,000.00https://www.sec.gov/Archives/edgar/data/1641489/000156218019004847/0001562180-19-004847-index.htm